Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
Studio LSD's Sloan Ratio for the quarter that ended in Mar. 2026 was 24.44%.
As of Mar. 2026, Studio LSD has a Sloan Ratio of 24.44%, indicating there is a warning stage of accrual build up.
Studio LSD (NSE:STUDIOLSD) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Studio LSD has a Sloan Ratio of 24.44%, indicating there is a warning stage of accrual build up.
Studio LSD Sloan Ratio % Related Terms
Studio LSD Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for Studio LSD's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:STUDIOLSD vs NFLX, DIS, WBD: Sloan Ratio % Comparison
For the Entertainment subindustry, Studio LSD's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Studio LSD Sloan Ratio % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Studio LSD's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Studio LSD's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Studio LSD's Sloan Ratio for the fiscal year that ended in Mar. 2026 is calculated as
For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data.
Studio LSD's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was -34.903 (Sep. 2025 ) + 24.901 (Mar. 2026 ) = ₹-10.0 Mil.
Studio LSD's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was -99.381 (Sep. 2025 ) + -123.164 (Mar. 2026 ) = ₹-222.5 Mil.
Studio LSD's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was 50.703 (Sep. 2025 ) + -65.868 (Mar. 2026 ) = ₹-15.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Studio LSD (NSE:STUDIOLSD) has a Sloan Ratio % of 24.44% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Studio LSD and its competitors.
Is Studio LSD's Sloan Ratio % too high?
Studio LSD's current Sloan Ratio % is 24.44%. Overall, Studio LSD has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Studio LSD's Sloan Ratio % compare to NFLX and DIS?
Studio LSD's Sloan Ratio % of 24.44% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Media - Diversified company?
A good Sloan Ratio % depends on the Media - Diversified industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Studio LSD and its competitors. Studio LSD's current Sloan Ratio % is 24.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Studio LSD stock overvalued right now?
Studio LSD (NSE:STUDIOLSD) has a current Sloan Ratio % of 24.44%. The current Sloan Ratio % is 24.44%. Studio LSD's overall GF Score™ is 19/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Studio LSD (NSE:STUDIOLSD), the current Sloan Ratio % is 24.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Studio LSD Ltd is a multimedia production house specializing in original and captivating stories, partnering with artists from the film and televisions industry. It is involved in every aspect of the content-making process, from idea to distribution and financing the projects, hiring actors and crew members, scouting locations, creating sets, managing the budgets, and overseeing the entire production and post-production process. The company is a production house specialised in creating compelling television content across various genres.
19GF Score
Get the complete analysis for NSE:STUDIOLSD
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:STUDIOLSD has been successfully added to your 
